CD8A and neoplasm: To this end, more recently, Dijkstra et al. co-cultured autologous colorectal or non-small lung cancer tumor organoids with peripheral blood lymphocytes, with the intention of increasing the number of tumor-specific CD8+ T cells to be infused in patients [154].